4//SEC Filing
Scanlon Meghan 4
Accession 0001225208-22-002933
CIK 0000885725other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:46 PM ET
Size
13.3 KB
Accession
0001225208-22-002933
Insider Transaction Report
Form 4
Scanlon Meghan
SVP,Pres,Urology Pelvic Health
Transactions
- Tax Payment
Common Stock
2022-02-17$42.83/sh−494$21,158→ 20,951 total - Exercise/Conversion
Common Stock
2022-02-17+1,583→ 21,445 total - Exercise/Conversion
Common Stock
2022-02-18+1,112→ 22,063 total - Tax Payment
Common Stock
2022-02-18$42.55/sh−327$13,914→ 21,736 total - Exercise/Conversion
Deferred Stock Units
2022-02-18−1,112→ 2,224 totalExp: 2024-02-18→ Common Stock (1,112 underlying) - Exercise/Conversion
Restricted Stock Units
2022-02-17−1,583→ 4,750 totalExp: 2025-02-17→ Common Stock (1,583 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F3]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
- [F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001801586
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:46 PM ET
- Size
- 13.3 KB